2 COMPOSITION FOR PREVENTING OR TREATING SARS CORONAVIRUS 2 INFECTION DISEASE
본 발명은 마크로락틴 유도체, 또는 이의 약학적으로 허용가능한 염을 포함하는 제2형 중증급성호흡기증후군 코로나바이러스 감염 질환 예방 또는 치료용 약학적 조성물을 제공한다. The present invention provides a pharmaceutical composition for preventing or treating SARS coronavirus 2 disease, the composition comprising a macrolactin derivative or a pharmaceutically acceptable sal...
Saved in:
| Main Authors | , , , , , , , |
|---|---|
| Format | Patent |
| Language | English Korean |
| Published |
02.01.2024
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | 본 발명은 마크로락틴 유도체, 또는 이의 약학적으로 허용가능한 염을 포함하는 제2형 중증급성호흡기증후군 코로나바이러스 감염 질환 예방 또는 치료용 약학적 조성물을 제공한다.
The present invention provides a pharmaceutical composition for preventing or treating SARS coronavirus 2 disease, the composition comprising a macrolactin derivative or a pharmaceutically acceptable salt thereof. |
|---|---|
| AbstractList | 본 발명은 마크로락틴 유도체, 또는 이의 약학적으로 허용가능한 염을 포함하는 제2형 중증급성호흡기증후군 코로나바이러스 감염 질환 예방 또는 치료용 약학적 조성물을 제공한다.
The present invention provides a pharmaceutical composition for preventing or treating SARS coronavirus 2 disease, the composition comprising a macrolactin derivative or a pharmaceutically acceptable salt thereof. |
| Author | KWON HYUNG JUN HWANG SUNG WOO PYO JAE SUNG KANG JAE SEON LEE IN CHUL PARK JI YOUNG CHUNG YU SEONG RYU YOUNG BAE |
| Author_xml | – fullname: KWON HYUNG JUN – fullname: HWANG SUNG WOO – fullname: LEE IN CHUL – fullname: CHUNG YU SEONG – fullname: PYO JAE SUNG – fullname: RYU YOUNG BAE – fullname: KANG JAE SEON – fullname: PARK JI YOUNG |
| BookMark | eNrjYmDJy89L5WTwNVJw9vcN8A_2DPH091Nw8w9SCAhyDXP1C_H0c1cA8kKCXB3B7GDHoGCg2iB_P8cwz6DQYAUjBU8_N1dnsD4Xz2BXx2BXHgbWtMSc4lReKM3NoOzmGuLsoZtakB-fWlyQmJyal1oS7x1kZGBkYgAEJkYWjsbEqQIA1VEwyw |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| DocumentTitleAlternate | 제2형 중증급성호흡기증후군 코로나바이러스 감염 질환의 예방 또는 치료용 조성물 |
| ExternalDocumentID | KR20240000428A |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_KR20240000428A3 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 13:11:24 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English Korean |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_KR20240000428A3 |
| Notes | Application Number: KR20230185695 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240102&DB=EPODOC&CC=KR&NR=20240000428A |
| ParticipantIDs | epo_espacenet_KR20240000428A |
| PublicationCentury | 2000 |
| PublicationDate | 20240102 |
| PublicationDateYYYYMMDD | 2024-01-02 |
| PublicationDate_xml | – month: 01 year: 2024 text: 20240102 day: 02 |
| PublicationDecade | 2020 |
| PublicationYear | 2024 |
| RelatedCompanies | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY KYUNGSUNG UNIVERSITY INDUSTRY COOPERATION FOUNDATION |
| RelatedCompanies_xml | – name: KYUNGSUNG UNIVERSITY INDUSTRY COOPERATION FOUNDATION – name: KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY |
| Score | 3.4674351 |
| Snippet | 본 발명은 마크로락틴 유도체, 또는 이의 약학적으로 허용가능한 염을 포함하는 제2형 중증급성호흡기증후군 코로나바이러스 감염 질환 예방 또는 치료용 약학적 조성물을 제공한다.
The present invention provides a pharmaceutical composition... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| Title | 2 COMPOSITION FOR PREVENTING OR TREATING SARS CORONAVIRUS 2 INFECTION DISEASE |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240102&DB=EPODOC&locale=&CC=KR&NR=20240000428A |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5qFfWmVfFRZUHJrVjz1EOQNNnYWPJgk4beinkIoiTFRvz7zq6p9tTbbmZZkoFvv_1mZzYAN9p9bgilWhq5MlB1lScBZNqgQFAWSB-ZknOh6Af6eKo-z7RZBz5WtTDintBvcTkiIipHvDdivV78B7EckVu5vM3e8FH96CamI7XqGOkJCVNyRiaNQie0Jds2J0wK2K9tKBSCtQXbuJE2OB5oOuJ1KYt1UnEPYCfC-armEDrvdQ_27NW_13qw67dH3ths0bc8Al8mduhHYezxuBJB_UbQgSkNEi94IthLGLVEO7ZYjGNZGFipx6YxkYkXuFQkjBDHi6kV02O4dmlijwf4XvM_N8wnbP0jlBPoVnVVngLRdV6gWhQvd8NCfUX9VPIC16GOO1I5f5DzM-hvmul8s_kC9nlXhB3kPnSbz6_yEom4ya6E_34AfVyDPw |
| link.rule.ids | 230,309,783,888,25576,76876 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fT4MwEL7MaZxvOjX-mNpEwxtxMsb0gRgGRZBRlsKWvRH5YWI02-Iw_vte66Z72lvLNQ295OPrd70rADfd-7wnlWrZyzuqbugiCSDrqgWCskD6yDq5EIohM7yR_jzpTmrwsaqFkfeEfsvLERFROeK9kt_r-X8Qy5G5lYvb7A0fzR7dxHSUpTpGekLCVJy-SYeRE9mKbZsBVxj_tbWlQrC2YBs32T2BBzrui7qU-TqpuPuwM8T5ptUB1N5nTWjYq3-vNWE3XB55Y3OJvsUhhBqxo3AYxb6IKxHUbwQdOKYs8dkTwV7CqSXbscVjHMsjZo19PoqJRnzmUpkwQhw_plZMj-DapYntqfhe6Z8b0oCvL6JzDPXpbFqeADEMUaBaFC937UJ_Rf1UigLXtoE7Ui1_0PJTaG2a6Wyz-QoaXhIO0oHPgnPYEyYZgtBaUK8-v8oLJOUqu5S-_AHRtIYy |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=2+COMPOSITION+FOR+PREVENTING+OR+TREATING+SARS+CORONAVIRUS+2+INFECTION+DISEASE&rft.inventor=KWON+HYUNG+JUN&rft.inventor=HWANG+SUNG+WOO&rft.inventor=LEE+IN+CHUL&rft.inventor=CHUNG+YU+SEONG&rft.inventor=PYO+JAE+SUNG&rft.inventor=RYU+YOUNG+BAE&rft.inventor=KANG+JAE+SEON&rft.inventor=PARK+JI+YOUNG&rft.date=2024-01-02&rft.externalDBID=A&rft.externalDocID=KR20240000428A |